Dr. Wei Tao is the Farokhzad Family Distinguished Chair for Innovation (Endowed Chair), Principal Investigator in the Center for Nanomedicine, and Faculty Member in the Department of Anesthesiology, Perioperative and Pain Medicine at Brigham and Women’s Hospital, Harvard Medical School. He is also the first Chaired Professor as an assistant professor in his institution. He has published over 100 papers in prestigious journals, including Nature/Science/Cell Press/PNAS family journals, and has continuously been a Clarivate’s Global Highly Cited Researcher since 2021. Dr. Tao’s research interests include biomaterials, nanotechnology, and drug delivery, as well as their various applications in translational medicine.

Dr. Tao has received multiple awards/grants including the American Heart Association (AHA) Transformational Project Award, American Lung Association (ALA) Courtney Cox Cole Lung Cancer Research Award, AHA Collaborative Sciences Award, ALA Cancer Discovery Award, American Society of Transplantation (AST) Career Transition Grant, Novo Nordisk ValidatioNN Award, AHA's Second Century Early Faculty Independence Award, U.S. METAvivor Early Career Investigator Award, Harvard/Brigham Health Technology Innovator Award, Anesthesia Department Basic Scientist Grant, Khoury Innovation Award, Center for Nanomedicine Research Fund, Nanotechnology Foundation, Stepping Strong Breakthrough Innovator Award, MIT Technology Review Top Chinese Innovators Under 35 (2020 TR35), World's Top 2% Scientist (continuously since 2019), Chemical Society Reviews (IF~46) Emerging Investigator Award, Advanced Materials (IF~30) Rising Star, Materials Today (IF~24) Rising Star Award, Angewandte Chemie (IF~17) Most Outstanding Referee, Materials Horizons (IF~13) Top 10 Outstanding Reviewers Award, etc. He also serves on numerous editorial boards including as Founding Editor-in-Chief of Biomedical Technology (Elsevier, KeAi's new journal), Associate Editor of Journal of Nanobiotechnology (IF~10; Springer Nature & BMC) and Aggregate (IF~19; Wiley); Editor of PNAS (IF~11); Guest Editor of eLife, etc.; Editorial Board Member of Bioactive Materials (IF~19; Elsevier, KeAi), Nano-Micro Letters (IF~27; Springer Nature), etc.; and Advisory Board Member of Matter (IF~19; Cell Press).

Group Website: https://www.weitaolab.com/